Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 EPS Loss of $0.13
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $430 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
- La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
